Sign In
12 Aug 2013 07:00
Β
DTR3
Β
NOTIFICATION OF TRANSACTIONS OF DIRECTORS/ PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND CONNECTED PERSONS
Β
All relevant boxes should be completed in block capital letters.
Β
1. | Name of the issuer Β ReNeuron Group plc | 2. | State whether the notification relates to (i) a transaction notified in accordance with DR 3.1.2RΝΎ or (ii) a disclosure made in accordance with LR 9.8.6R(1); or (iii) in accordance with section 793 of the Companies Act 2006 Β (i) Β |
3. | Name of person discharging managerial responsibilities/director Β Dr. Paul Harper | 4. | State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person Β Director named in 3. Β |
5. | Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest 1 Β Interest of person named in 3 Β | 6. | Description of shares (including class), debentures or derivatives or financial instruments relating to shares Β Ordinary Shares Β Β |
7. | Name of registered shareholders(s) and, if more than one, the number of shares held by each of them Β Person named in 3 Β | 8. | State the nature of the transaction Β Placing of Ordinary Shares |
9. | Number of shares, debentures or financial instruments relating to shares acquired Β Acquisition of 200,000 Ordinary Shares | 10. | Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage) Β 0.011% Β |
11. | Number of shares, debentures or financial instruments relating to shares disposed Β Β Β | 12. | Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage) Β Β Β |
13. | Price per share or value of transaction Β 2.5 pence per Ordinary Share Β | 14. | Date and place of transaction Β 9 August 2013 |
15. | Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage) Β Dr. Paul Harper is interested in a total of 451,709 Ordinary Shares in the Company representing approximately 0.025% of issued Ordinary Shares. Β | 16. | Date issuer informed of transaction Β 9 August 2013 |
Β
If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes
Β
17. | Date of grant Β Β | 18. | Period during which or date on which it can be exercised Β | |||||||||||||||||||||||||||
19. | Total amount paid (if any) for grant of the option | 20. | Description of shares or debentures involved (class and number) Β | |||||||||||||||||||||||||||
21. | Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise Β | 22. | Total number of shares or debentures over which options held following notification | |||||||||||||||||||||||||||
23. | Any additional information Β See table of options held by Dr. Paul Harper below: Β Β Β
| 24. | Name of contact and telephone number for queries Β Pat Huggins, Reneuron Group Plc +44 (0)1483 302560 |
Β
Β
Name of authorised official of issuer responsible for making notification: Β Patrick Huggins, Head of Finance and Company Secretary Β Date of notification: 9 August 2013 Β Β |
Β
Follow the stocks
